Dudediligence.

GT Biopharma, Inc

GTBPNASDAQ · Pharmaceutical Preparations
Write an idea

Financing

SEC filings to 2026-10-05 · every row opens its filing

Shares on issue

44.7M

on 2026-06-30, from 1.38M on 2024-03-31 10-Q ↗

a raise that quarter, at its price

Newest

S-3 of 2025-03-06. Not read yet. S-3 ↗

10 of its filings are not read yet.

Warrants

400K

Warrants of every class as tagged in the XBRL facts on 2026-04-30. 10-Q ↗

Cash

1.4 quarters

$5.0M on 2026-06-30 ÷ $3.6M a quarter of operating cash used, the average of four quarters. 10-Q ↗

Raised
DateWhatSharesPriceGrossFiling
2026-09-18Private placementnot readnot read$7.8M8-K ↗
2026-09-14Private placementnot readnot read$7.5M8-K ↗

Also on file: a 1-for-10 reverse split, 2024-07-01 8-K ↗